These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 25973137

  • 1. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
    Peng H, Wang X, Zhang P, Sun T, Ren X, Xia Z.
    Int J Clin Exp Pathol; 2015; 8(2):2259-66. PubMed ID: 25973137
    [Abstract] [Full Text] [Related]

  • 2. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X, Quan J, Li Z, Zhao L, Zhou L, Jinling X, Weijie X, Guan X, Li H, Yang S, Gui Y, Lai Y.
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [Abstract] [Full Text] [Related]

  • 3. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M, Gu M, Zhang K, Zhou J, Wang Z, Da J.
    Diagn Pathol; 2015 Apr 09; 10():24. PubMed ID: 25890121
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y, Guan B, Liu J, Zhang Z, He S, Zhan Y, Su B, Han H, Zhang X, Wang B, Li X, Zhou L, Zhao W.
    EBioMedicine; 2019 Jun 09; 44():439-451. PubMed ID: 31130475
    [Abstract] [Full Text] [Related]

  • 5. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C, Li Z, Chen P, Quan J, Pan X, Zhao L, Zhou L, Lai Y, He T, Xu W, Xu J, Guan X, Li H, Yang S, Hu Y, Lai Y.
    Life Sci; 2018 Sep 15; 209():481-489. PubMed ID: 30138594
    [Abstract] [Full Text] [Related]

  • 6. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.
    Chen Q, Liu T, Bao Y, Zhao T, Wang J, Wang H, Wang A, Gan X, Wu Z, Wang L.
    Cancer Lett; 2020 Jan 28; 469():68-77. PubMed ID: 31629934
    [Abstract] [Full Text] [Related]

  • 7. Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.
    Nakata W, Uemura M, Sato M, Fujita K, Jingushi K, Ueda Y, Kitae K, Tsujikawa K, Nonomura N.
    Oncotarget; 2015 Aug 28; 6(25):21645-54. PubMed ID: 26046464
    [Abstract] [Full Text] [Related]

  • 8. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
    Liu S, Wang Y, Li W, Yu S, Wen Z, Chen Z, Lin F.
    Biomed Pharmacother; 2019 Nov 28; 119():109406. PubMed ID: 31514066
    [Abstract] [Full Text] [Related]

  • 9. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL, Xing L, Wang L, Song WT, Li DB, Wang Y, Gu YW, Liu MM, Ni WJ, Zhang P, Ma X, Zhang X, Yao J, Chen Y, An RH.
    Aging (Albany NY); 2019 Aug 10; 11(15):5705-5725. PubMed ID: 31400752
    [Abstract] [Full Text] [Related]

  • 10. Mechanism and function of decreased FOXO1 in renal cell carcinoma.
    Zhou L, Yin B, Liu Y, Hong Y, Zhang C, Fan J.
    J Surg Oncol; 2012 Jun 15; 105(8):841-7. PubMed ID: 22213032
    [Abstract] [Full Text] [Related]

  • 11. Long Noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) Promotes Renal Cell Carcinoma Progression and Metastasis by Negatively Regulating miR-137.
    Zhao S, Wang Y, Luo M, Cui W, Zhou X, Miao L.
    Med Sci Monit; 2018 Jun 06; 24():3824-3831. PubMed ID: 29874202
    [Abstract] [Full Text] [Related]

  • 12. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL, Pan WG, Li KL, Mao YJ, Liu SD, Zhang RM.
    Cancer Biother Radiopharm; 2020 Jun 06; 35(5):377-386. PubMed ID: 31971830
    [Abstract] [Full Text] [Related]

  • 13. Cholesterol promotes the migration and invasion of renal carcinoma cells by regulating the KLF5/miR-27a/FBXW7 pathway.
    Liu Z, Liu X, Liu S, Cao Q.
    Biochem Biophys Res Commun; 2018 Jul 07; 502(1):69-75. PubMed ID: 29782853
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y, Chen D, Su Z, Li Y, Liu J, Jin L, Shi M, Jiang Z, Qi Z, Gui Y, Yang S, Mao X, Wu X, Lai Y.
    Mol Med Rep; 2016 Feb 07; 13(2):1420-6. PubMed ID: 26648244
    [Abstract] [Full Text] [Related]

  • 15. Inverse correlation of miR-27a-3p and CDH5 expression serves as a diagnostic biomarker of proliferation and metastasis of clear cell renal carcinoma.
    Wang Y, Zhou X, Han P, Lu Y, Zhong X, Yang Y, Li D, Liu D, Li Q, Pan N, Mo Y, Luo W, Li P, Zhou X, Liudmila M.
    Pathol Res Pract; 2021 Apr 07; 220():153393. PubMed ID: 33740544
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X, Xin S, He Z, Che X, Wang J, Xiao X, Chen J, Song X.
    Cell Physiol Biochem; 2014 Apr 07; 33(6):1631-42. PubMed ID: 24902663
    [Abstract] [Full Text] [Related]

  • 17. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C, Wang S, Ye ZQ, Chen ZQ.
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec 07; 36(6):852-858. PubMed ID: 27924503
    [Abstract] [Full Text] [Related]

  • 18. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C, Wu C, Yang Q, Ding M, Zhong J, Zhang CY, Ge J, Wang J, Zhang C.
    Oncotarget; 2016 Nov 08; 7(45):73888-73902. PubMed ID: 27729617
    [Abstract] [Full Text] [Related]

  • 19. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H, Chen B, Duan B, Zheng J, Wu X.
    Mol Med Rep; 2016 Oct 08; 14(4):3343-9. PubMed ID: 27498834
    [Abstract] [Full Text] [Related]

  • 20. Expression and functional role of miR-29b in renal cell carcinoma.
    Xu Y, Zhu J, Lei Z, Wan L, Zhu X, Ye F, Tong Y.
    Int J Clin Exp Pathol; 2015 Oct 08; 8(11):14161-70. PubMed ID: 26823729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.